1. Kessler RC, Berglund P, Chiu WT, et al. The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res. 2004;13:69–92.
2. Fournier, J.C., DeRubeis, R.J., Hollon, S.D., Dimidijian, S, Amsterdam, J.D., Shelton, R.C., Fawcett, J. (2010) Antidepressant Drug Effects and Depression Severity, A Patient-Level Meta-analysis. JAMA. 2010;303(1):47-53.
3. Penn, E. and Tracy, D.K., (2012). The drugs don’t work? antidepressants and the current and future pharmacological management of depression. Ther Adv Psychopharmacol. 2012 Oct; 2(5): 179–188.
4. Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment, 1(2). Article ID 2a.
5. Khan A, Warner HA, Brown WA. (2000) Symptom reduction and suicide risk in patients treated
with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry. 2000 Apr; 57(4):311-7.
6. Bet PM, Hugtenburg JG, Penninx BW, Hoogendijk WJ. (2013). Side effects of antidepressants during long-term use in a naturalistic setting. Eur Neuropsychopharmacol. 2013 Nov;23(11):1443-51.
7. Cartwright C, Gibson K, Read J, Cowan O, Dehar T. (2016). Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Prefer Adherence. 2016; 10: 1401–1407.
8. Dolan RJ, Calloway SP, Fonagy P, De Souza, FVA, Wakeling A. (1985). Life events, depression and hypothalamic-pituitary-adrenal axis function. British Journal of Psychiatry, 147, 429-433.
9. Breier A, Albus M, Pickar D, Zahn TP, Wolkowitz OM, Paul, SM (1987). Controllable and uncontrollable stress in humans: Alterations in mood and neuroendocrine and psychophysiological function. American Journal of Psychiatry, 144, 1419-1425.
10. Post, J. M. (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorders. American Journal of Psychiatry, 149, 999-1010.
11. Dinan, T.G. (1994). Glucocorticoids and the genesis of depressive illness: A psychobiologicalmodel. British Journal of Psychiatry, 164, 365-371.
12. Croes, S.,Merz,P., & Netter,P. (1993). Cortisol reaction in success and failure condition in endogenous depressed patients and controls. Psychoneuroendocrinology, 18, 23-35.
13. Hammen C, Kim EY, Eberhart NK, Brennan PA. (2009). Chronic and acute stress and the prediction of major depression in women. Depress Anxiety. 2009;26(8):718-23.
14. Lenze EJ, Mantella RC, Shi P, Goate AM, Nowotny P, Butters MA, Andreescu C, Thompson PA, Rollman BL. (2005). Elevated cortisol in older adults with Generalized Anxiety Disorder is reduced by treatment: a placebo-controlled evaluation of Escitalopram. Psychosom Med. 2005; 67(5): 734-439.
15. Fischer S, Strawbridge R, Vives AH, Cleare AJ. (2017). Cortisol as a predictor of psychological therapy response in depressive disorders: systematic review and meta-analysis. Br J Psychiatry. 2017 Feb;210(2):105-109.
16. Bowen CJ. (2018) Preliminary Findings on the Importance of Kinetic Oxygen in Managing the Impact of Stress.
17. Knop U. (2003) Report on a two-stage controlled study, using heart-rate-variability-measurements (HRV) in respect of the effectiveness of Airnergy+ Oxygen-Therapy.
18. Schollmann C. (2004) Concentrated Oxygen and Activated Respiratory Air: A comparison between the physiological effects of two inhalation applications. A study involving healthy test persons. 2004, Die Naturheilkunde No. 2 / 2004